Skip to main content

Nomura Holdings Inc

Source: SEC Form 13F · as of Mar 2026

Nomura Holdings Inc holds 40 biotech & pharma companies tracked by BioSniper, totaling $271.7M in value as of Mar 2026 (SEC Form 13F).

Companies held

40

Total value held

$271.7M

BioSniper AIPage evidence connected

Prepared research question

What matters most for Teva Pharmaceutical Industries Limited (TEVA)—catalysts, financial risk and supporting evidence?

Run cited research

Traceable citations · Unknowns marked

CompanySharesValue
TEVATeva Pharmaceutical Industries Limited2,338,602$70.4M
BBIOBridgeBio Pharma, Inc.318,563$23.7M
LGNDLigand Pharmaceuticals Incorporated114,355$22.8M
GILDGILEAD SCIENCES, INC.161,713$22.5M
ANIPANI PHARMACEUTICALS INC237,225$18.2M
KNSAKiniksa Pharmaceuticals International, plc342,939$16.5M
REGNREGENERON PHARMACEUTICALS, INC.19,562$15.1M
JAZZJazz Pharmaceuticals plc60,151$11.4M
ONCBeOne Medicines Ltd.30,942$9.2M
IONSIONIS PHARMACEUTICALS INC114,080$8.6M
APGEApogee Therapeutics, Inc.88,561$7.5M
SMMTSummit Therapeutics Inc.313,981$6.0M
ALNYALNYLAM PHARMACEUTICALS, INC.14,299$4.7M
AXSMAxsome Therapeutics, Inc.24,637$4.2M
INVAInnoviva, Inc.144,087$3.4M
INSMINSMED Inc19,045$3.1M
PVLAPALVELLA THERAPEUTICS, INC.24,008$3.0M
ARVNARVINAS, INC.253,609$2.7M
TERNTerns Pharmaceuticals, Inc.50,000$2.6M
MRNAModerna, Inc.40,543$2.1M
RNAAtrium Therapeutics Inc.137,380$1.8M
BMRNBIOMARIN PHARMACEUTICAL INC30,000$1.7M
RVMDREVOLUTION MEDICINES, INC.17,359$1.7M
INCYIncyte Corp.14,375$1.4M
EXELEXELIXIS, INC.28,844$1.2M
PTGXProtagonist Therapeutics, Inc10,479$1.1M
STOKStoke Therapeutics, Inc.26,891$876K
OLMAOlema Pharmaceuticals, Inc.41,960$626K
ARQTArcutis Biotherapeutics, Inc.22,943$541K
VRDNViridian Therapeutics, Inc.\DE22,205$434K
OCULOCULAR THERAPEUTIX, INC50,000$424K
IMVTImmunovant, Inc.16,011$398K
QUREuniQure N.V.20,000$327K
DNTHDianthus Therapeutics, Inc. /DE/3,837$322K
AGIOAGIOS PHARMACEUTICALS, INC.9,176$310K
CYTKCYTOKINETICS INC4,130$272K
NGNENeurogene Inc.12,724$257K
OGNOrganon & Co.37,200$223K
KURAKura Oncology, Inc.14,985$122K
ADAGAdagene Inc.14,710$58K

13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.